Joachim F. Wernicke
Chief Tech/Sci/R&D Officer en REPROS THERAPEUTICS INC .
Perfil
Joachim F.
Wernicke is currently the Chief Medical Officer at Repros Therapeutics, Inc. He previously worked as the Vice President-Clinical & Regulatory Affairs at LivaNova USA, Inc. and as an Advisor at MediGen Group LLC.
He holds a doctorate degree from the University of California, Los Angeles and another doctorate degree from the University of California, Irvine.
Cargos activos de Joachim F. Wernicke
| Empresas | Cargo | Inicio |
|---|---|---|
| REPROS THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 05/02/2013 |
Antiguos cargos conocidos de Joachim F. Wernicke.
| Empresas | Cargo | Fin |
|---|---|---|
| CYBERONICS, INC. | General Counsel | - |
MediGen Group LLC
 MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas | Private Equity Investor | - |
Formación de Joachim F. Wernicke.
| University of California, Los Angeles | Doctorate Degree |
| University of California, Irvine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
LivaNova USA, Inc.
 LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX. | Health Technology |
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
MediGen Group LLC
MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas | Finance |
- Bolsa de valores
- Insiders
- Joachim F. Wernicke
